369 related articles for article (PubMed ID: 33455473)
21. The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.
Lemon LS; Naimi A; Caritis SN; Platt RW; Venkataramanan R; Bodnar LM
Paediatr Perinat Epidemiol; 2018 Mar; 32(2):213-222. PubMed ID: 29372750
[TBL] [Abstract][Full Text] [Related]
22. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder.
Enns B; Krebs E; Whitehurst DGT; Jutras-Aswad D; Le Foll B; Socias ME; Nosyk B;
Drug Alcohol Depend; 2023 Jun; 247():109893. PubMed ID: 37120920
[TBL] [Abstract][Full Text] [Related]
25. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder.
Abdelwahab M; Petrich M; Wang H; Walker E; Cleary EM; Rood KM
Am J Obstet Gynecol MFM; 2022 May; 4(3):100582. PubMed ID: 35123110
[TBL] [Abstract][Full Text] [Related]
27. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
28. Opioid Use Disorder and Perinatal Outcomes.
Piske M; Homayra F; Min JE; Zhou H; Marchand C; Mead A; Ng J; Woolner M; Nosyk B
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34479983
[TBL] [Abstract][Full Text] [Related]
29. Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis.
Qian G; Humphreys K; Goldhaber-Fiebert JD; Brandeau ML
Drug Alcohol Depend; 2024 Mar; 256():111112. PubMed ID: 38335797
[TBL] [Abstract][Full Text] [Related]
30. "Will My Baby Be OK?" A Qualitative Analysis of Pregnant Women's Suboxone
Moore DJ; Butzlaff A
J Am Psychiatr Nurses Assoc; 2023; 29(3):185-193. PubMed ID: 37038973
[TBL] [Abstract][Full Text] [Related]
31. The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.
Tran EL; Kim SY; England LJ; Green C; Dang EP; Broussard CS; Fehrenbach N; Hudson A; Yowe-Conley T; Gilboa SM; Meaney-Delman D
J Womens Health (Larchmt); 2020 Dec; 29(12):1491-1499. PubMed ID: 33227221
[TBL] [Abstract][Full Text] [Related]
32. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
Bivin B; Waring A; Alves P
J Am Assoc Nurse Pract; 2019 Dec; 33(2):119-125. PubMed ID: 31809398
[TBL] [Abstract][Full Text] [Related]
33. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
[TBL] [Abstract][Full Text] [Related]
34. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
Meyer MC; Johnston AM; Crocker AM; Heil SH
J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
[TBL] [Abstract][Full Text] [Related]
35. Neonatal opioid withdrawal syndrome.
Sutter MB; Leeman L; Hsi A
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
[TBL] [Abstract][Full Text] [Related]
36. Opioid Use in Pregnancy.
Tobon AL; Habecker E; Forray A
Curr Psychiatry Rep; 2019 Nov; 21(12):118. PubMed ID: 31734808
[TBL] [Abstract][Full Text] [Related]
37. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
[TBL] [Abstract][Full Text] [Related]
38. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
39. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.
Gomes T; McCormack D; Bozinoff N; Tadrous M; Antoniou T; Munro C; Campbell T; Paterson JM; Mamdani M; Sproule B
Addiction; 2022 Jul; 117(7):1972-1981. PubMed ID: 35257434
[TBL] [Abstract][Full Text] [Related]
40. Association of Maternal Buprenorphine or Methadone Dose with Fetal Growth Indices and Neonatal Abstinence Syndrome.
Coulson CC; Lorencz E; Rittenhouse K; Ramage M; Lorenz K; Galvin SL
Am J Perinatol; 2021 Jan; 38(1):28-36. PubMed ID: 31421639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
